F13B and thrombotic disease: Second, we benefitted from aggregating evidence across many SNPs, including those that did not achieve genome-wide significance in earlier genetic studies of coagulation and stroke, but this provides no resolution at individual SNPs, and we were consequently unable to comment on specific FXIIIB polymorphisms previously reported to be associated with thrombotic disease (stroke).